The Center for Genomics and Transcriptomics is now offering sequencing-based diagnostic tests for epilepsy, dementia, amyotrophic lateral sclerosis, Parkinson's disease, and hereditary eye diseases, joining a small but growing number of organizations offering diagnostic panels on next-generation sequencing platforms.
